Baclofen oral - Schwarz Pharma

Drug Profile

Baclofen oral - Schwarz Pharma

Alternative Names: Baclofen ODT; Kemstro

Latest Information Update: 12 Oct 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Schwarz Pharma USA
  • Class Aminobutyric acids; Antispastics; Muscle relaxants; Small molecules
  • Mechanism of Action GABA B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Muscle spasticity

Most Recent Events

  • 01 Oct 2010 No development reported - Registered for Spasticity in USA (PO)
  • 09 Jan 2009 Baclofen orally disintegrating tablets exclusively licensed to Azur Pharma in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top